Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume $1.68 -0.08 (-4.55%) (As of 05:20 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Evaxion Biotech A/S Short Interest DataEvaxion Biotech A/S (EVAX) has a short interest of 52,600 shares. This marks a -21.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 222,186 shares to cover all short positions.Current Short Interest52,600 sharesPrevious Short Interest67,400 sharesChange Vs. Previous Month-21.96%Dollar Volume Sold Short$137,812.00Short Interest Ratio1.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares5,580,000 sharesPercentage of Shares Shorted0.94%Today's Trading Volume41,395 sharesAverage Trading Volume222,186 sharesToday's Volume Vs. Average19% Short Selling Evaxion Biotech A/S? Sign up to receive the latest short interest report for Evaxion Biotech A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVAX Short Interest Over TimeEVAX Days to Cover Over TimeEVAX Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Evaxion Biotech A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202452,600 shares $137,812.00 -22.0%N/A1.1 $2.62 10/15/202467,400 shares $181,306.00 -21.1%N/A1.4 $2.69 9/30/202485,400 shares $265,594.00 +286.4%N/A1.7 $3.11 9/15/202422,100 shares $66,300.00 -35.2%N/A0.6 $3.00 8/31/202434,100 shares $104,005.00 -24.9%N/A0.8 $3.05 8/15/202445,400 shares $135,746.00 +9.4%N/A1.1 $2.99 Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 7/31/202441,500 shares $118,690.00 -20.4%N/A1.1 $2.86 7/15/202452,100 shares $164,115.00 -40.8%N/A1.4 $3.15 6/30/202488,000 shares $255,200.00 +93.8%N/A2.3 $2.90 6/15/202445,400 shares $140,740.00 +6.3%N/A1 $3.10 5/31/202442,700 shares $156,709.00 -10.9%N/A1.5 $3.67 5/15/202447,900 shares $180,104.00 -10.0%N/A1.4 $3.76 4/30/202453,200 shares $222,908.00 +11.3%N/A1 $4.19 4/15/202447,800 shares $195,980.00 +12.2%N/A0.1 $4.10 3/31/202442,600 shares $136,320.00 -0.9%N/A0.1 $3.20 3/15/202443,000 shares $128,570.00 +56.4%N/A0.1 $2.99 2/29/202427,500 shares $99,000.00 +41.8%N/A0 $3.60 2/15/202419,400 shares $80,510.00 -61.0%N/A0 $4.15 1/31/202449,800 shares $195,714.00 +325.6%N/A0.1 $3.93 1/15/202411,700 shares $93,483.00 -92.5%N/A0.4 $7.99 12/31/2023155,800 shares $106,832.06 -9.1%N/A1.7 $0.69 12/15/2023171,400 shares $113,124.00 -26.9%N/A1.8 $0.66 11/30/2023234,300 shares $187,205.70 +7.8%N/A1.5 $0.80 11/15/2023217,400 shares $161,963.00 -22.8%N/A1.5 $0.75 10/31/2023281,600 shares $315,392.00 -22.5%N/A2.1 $1.12 10/15/2023363,400 shares $308,526.60 -31.6%N/A3.1 $0.85 9/30/2023531,500 shares $442,739.50 +118.9%N/A4.6 $0.83 9/15/2023242,800 shares $182,609.88 +38.5%N/A2.2 $0.75 8/31/2023175,300 shares $145,516.53 -23.8%N/A2.8 $0.83 8/15/2023230,000 shares $233,059.00 -30.7%N/A1.1 $1.01 7/31/2023331,700 shares $411,308.00 -9.9%N/A1.5 $1.24 7/15/2023368,000 shares $463,680.00 -15.6%N/A1.8 $1.26 6/30/2023436,200 shares $567,060.00 -18.4%N/A1.9 $1.30 6/15/2023534,300 shares $694,590.00 +110.1%N/A2.2 $1.30 5/31/2023254,300 shares $386,536.00 -4.0%N/A1.1 $1.52 5/15/2023264,800 shares $415,736.00 +5.5%N/A2.8 $1.57 4/30/2023251,100 shares $316,386.00 -34.3%N/A0.7 $1.26 4/15/2023382,100 shares $596,076.00 -12.1%N/A1 $1.56 3/31/2023434,700 shares $491,211.00 +24.2%N/A1 $1.13 3/15/2023350,100 shares $378,108.00 +31.6%N/A0.6 $1.08Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 2/28/2023266,100 shares $409,794.00 -20.6%N/A0.4 $1.54 2/15/2023335,200 shares $526,264.00 +74.6%N/A0.6 $1.57 1/31/2023192,000 shares $309,120.00 -11.0%N/A0.3 $1.61 1/15/2023215,800 shares $334,490.00 +572.3%N/A0.7 $1.55 12/30/202232,100 shares $56,977.50 -9.8%N/A0.2 $1.78 12/15/202235,600 shares $71,200.00 +16.0%N/A0.5 $2.00 11/30/202230,700 shares $66,926.00 -26.0%N/A0 $2.18 11/15/202241,500 shares $97,940.00 -39.4%N/A0.1 $2.36 10/31/202268,500 shares $178,100.00 -45.8%N/A0.1 $2.60 10/15/2022126,300 shares $368,796.00 -36.5%N/A0.2 $2.92 9/30/2022198,800 shares $522,844.00 +9.7%N/A0.3 $2.63 9/15/2022181,200 shares $373,272.00 -0.7%N/A0.2 $2.06 8/31/2022182,400 shares $428,640.00 -2.6%N/A5.2 $2.35 8/15/2022187,200 shares $548,496.00 -3.8%N/A4.6 $2.93 7/31/2022194,600 shares $595,476.00 +6.5%N/A0.5 $3.06 7/15/2022182,700 shares $442,134.00 -9.8%N/A0.5 $2.42 6/30/2022202,600 shares $388,992.00 +13.1%N/A0.5 $1.92 6/15/2022179,100 shares $300,888.00 +3.0%N/A0.5 $1.68 5/31/2022173,900 shares $340,844.00 -35.6%N/A0.5 $1.96 5/15/2022270,100 shares $469,974.00 +4,810.9%N/A0.7 $1.74 4/30/20225,500 shares $15,400.00 -41.5%N/A0.2 $2.80 4/15/20229,400 shares $27,072.00 -34.7%N/A0.2 $2.88 3/31/202214,400 shares $43,632.00 +84.6%N/A0.2 $3.03 3/15/20227,800 shares $20,826.00 +116.7%N/A0.1 $2.67 2/28/20223,600 shares $10,944.00 -82.0%N/A0 $3.04 2/15/202220,000 shares $63,800.00 -58.6%N/A0.1 $3.19 1/31/202248,300 shares $151,662.00 -3.0%N/A0.2 $3.14 1/15/202249,800 shares $203,682.00 +28.7%N/A0 $4.09 12/31/202138,700 shares $171,054.00 +25.7%N/A0 $4.42 12/15/202130,800 shares $126,588.00 +37.5%N/A0 $4.11 11/30/202122,400 shares $104,384.00 -57.1%N/A0 $4.66 11/15/202152,200 shares $324,162.00 +78.2%N/A0.1 $6.21 10/29/202129,300 shares $222,973.00 +229.2%N/A0 $7.61 10/15/20218,900 shares $70,488.00 -77.2%N/A0.1 $7.92 9/30/202139,000 shares $375,960.00 -27.9%N/A0.4 $9.64 9/15/202154,100 shares $444,161.00 +57.7%N/A0.6 $8.21 8/31/202134,300 shares $223,979.00 -2.8%N/A0.3 $6.53 8/13/202135,300 shares $205,093.00 No ChangeN/A0.5 $5.81 EVAX Short Interest - Frequently Asked Questions What is Evaxion Biotech A/S's current short interest? Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 52,600 shares of EVAX short. Learn More on Evaxion Biotech A/S's current short interest. What is a good short interest ratio for Evaxion Biotech A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVAX shares currently have a short interest ratio of 1.0. Learn More on Evaxion Biotech A/S's short interest ratio. Is Evaxion Biotech A/S's short interest increasing or decreasing? Evaxion Biotech A/S saw a decline in short interest in October. As of October 31st, there was short interest totaling 52,600 shares, a decline of 22.0% from the previous total of 67,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evaxion Biotech A/S's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Evaxion Biotech A/S: Atara Biotherapeutics, Inc. (16.03%), Protara Therapeutics, Inc. (13.28%), Achilles Therapeutics plc (0.41%), Elevation Oncology, Inc. (12.42%), OKYO Pharma Limited (1.11%), Passage Bio, Inc. (3.21%), Dyadic International, Inc. (0.87%), Surrozen, Inc. (1.47%), Aligos Therapeutics, Inc. (4.78%), SAB Biotherapeutics, Inc. (0.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Evaxion Biotech A/S stock? Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evaxion Biotech A/S? A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further. How often is Evaxion Biotech A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Atara Biotherapeutics Short Interest Data Protara Therapeutics Short Interest Data Achilles Therapeutics Short Interest Data Elevation Oncology Short Interest Data OKYO Pharma Short Interest Data Passage Bio Short Interest Data Dyadic International Short Interest Data Surrozen Short Interest Data Aligos Therapeutics Short Interest Data SAB Biotherapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVAX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
